ACM
RMD icon

Anfield Capital Management’s ResMed RMD Stock Holding History

Anfield Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.08K Hold
36
– – ﹤0.01% 461
2025
Q4 		$8.67K Hold
36
– – ﹤0.01% 351
2025
Q3 		$9.85K Hold
36
– – ﹤0.01% 334
2025
Q2 		$9.29K Hold
36
– – ﹤0.01% 304
2025
Q1 		$8.06K Hold
36
– – ﹤0.01% 266
2024
Q4 		$8.23K Hold
36
– – ﹤0.01% 259
2024
Q3 		$8.79K Hold
36
– – ﹤0.01% 245
2024
Q2 		$6.89K Buy
+36
New +$7.3K ﹤0.01% 225

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Anfield Capital Management's RMD Position: Q1 2026 in Review

Anfield Capital Management held its ResMed (RMD) position steady in Q1 2026 at 36 shares worth $8.08K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Anfield Capital Management first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $9.85K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Anfield Capital Management held 36 shares of ResMed worth $8.08K as of Q1 2026.
  • Anfield Capital Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #461 holding.
  • Anfield Capital Management first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • Anfield Capital Management's ResMed position peaked at $9.85K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.